These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1985810)

  • 21. A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation.
    Winston DJ; Antin JH; Wolff SN; Bierer BE; Small T; Miller KB; Linker C; Kaizer H; Lazarus HM; Petersen FB; Cowan MJ; Ho WG; Wingard JR; Schiller GJ; Territo MC; Jiao J; Petrarca MA; Tonetta SA
    Bone Marrow Transplant; 2001 Jul; 28(2):187-96. PubMed ID: 11509937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone marrow transplantation for aplastic anaemia and leukaemia.
    Gordon-Smith EC
    Triangle; 1978; 17(2):63-73. PubMed ID: 384625
    [No Abstract]   [Full Text] [Related]  

  • 23. [Bone marrow transplantation. Indications in adult patients with leukemia or aplastic anemia].
    Evensen SA; Frøland SS; Stavem P; Albrechtsen D; Flatmark A
    Tidsskr Nor Laegeforen; 1984 Aug; 104(23):1542-4. PubMed ID: 6385336
    [No Abstract]   [Full Text] [Related]  

  • 24. [Bone marrow transplantation in patients with acute leukemia and aplastic anemia (author's transl)].
    Yamada K
    Rinsho Ketsueki; 1980 Apr; 21(4):457-64. PubMed ID: 6997545
    [No Abstract]   [Full Text] [Related]  

  • 25. Risk factors for septicemia during aplastic period after allogeneic bone marrow transplantation.
    Sparrelid E; Hägglund H; Remberger M; Ljungman P; Malmborg AS; Winiarski J; Andersson J; Ringdén O
    Transplant Proc; 1995 Dec; 27(6):3530. PubMed ID: 8540085
    [No Abstract]   [Full Text] [Related]  

  • 26. [Transplantation of bone marrow in aplastic anemia and leukemias (author's transl)].
    Torlontano G; Iacone A
    Haematologica; 1979 Oct; 64 Suppl():239-48. PubMed ID: 44252
    [No Abstract]   [Full Text] [Related]  

  • 27. The influence of the microbial flora on incidence of graft-versus-host disease in human allogeneic bone marrow transplantation.
    Schmeiser T; Kurrle E; Arnold R; Heit W; Krieger D; Kubanek B; Heimpel H
    Prog Clin Biol Res; 1985; 181():433-5. PubMed ID: 3895247
    [No Abstract]   [Full Text] [Related]  

  • 28. Malignant diseases after allogeneic bone marrow transplantation: an updated overview.
    Socié G; Henry-Amar M; Devergie A; Esperou-Bourdeau H; Ribaud P; Traineau R; Gluckman E
    Nouv Rev Fr Hematol (1978); 1994; 36 Suppl 1():S75-7. PubMed ID: 8177721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New Bone Marrow Transplant Center begins treatment for acute leukemia and aplastic anemia.
    Conrad ME
    Ala J Med Sci; 1981 Jan; 18(1):94-5. PubMed ID: 7015902
    [No Abstract]   [Full Text] [Related]  

  • 30. Bone marrow transplantation in children.
    Schwitter G; Beach J
    Nurs Clin North Am; 1976 Mar; 11(1):49-57. PubMed ID: 3769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Bone marrow transplantation for aplastic anemia and acute leukemia (author's transl)].
    Nakamura S
    Rinsho Ketsueki; 1980 Apr; 21(4):465-71. PubMed ID: 6997546
    [No Abstract]   [Full Text] [Related]  

  • 32. Bone marrow transplantation (1958-1978) : conditioning and graft-versus-host disease, indications in aplasias and leukemias.
    Mathe G; Schwarzenberg L
    Pathol Biol (Paris); 1979 Jun; 27(6):337-43. PubMed ID: 159426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of 500 bone marrow transplants from unrelated donors (UR-BMT) facilitated by the Japan Marrow Donor Program: confirmation of UR-BMT as a standard therapy for patients with leukemia and aplastic anemia.
    Kodera Y; Morishima Y; Kato S; Akiyama Y; Sao H; Matsuyama T; Kawa K; Sakamaki H; Nakagawa S; Hirabayashi N; Dohi H; Okamoto S; Hiraoka A; Gondo H; Tsuchida M; O H; Harada M; Asano S; Juji T; Sasazuki T; Takaku F
    Bone Marrow Transplant; 1999 Nov; 24(9):995-1003. PubMed ID: 10556959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Transplantation of hematopoietic stem cells].
    Hertenstein B; Novotny J; Ebell W; Ganser A
    Internist (Berl); 1996 Mar; 37(3):295-303. PubMed ID: 8919947
    [No Abstract]   [Full Text] [Related]  

  • 35. Allogeneic marrow transplantation using matched sibling donors.
    Thomas ED
    Transplant Proc; 1974 Dec; 6(4 Suppl 1):115-9. PubMed ID: 4155158
    [No Abstract]   [Full Text] [Related]  

  • 36. CD34-enriched peripheral stem cells infusion for graft insufficiency treatment in a pediatric patient with severe aplastic anemia after allogeneic bone marrow transplantation.
    Trakhtman P; Shipicina I; Balashov D; Scvortsova J; Dishlevaja Z; Blagonravova O; Maschan A
    Bone Marrow Transplant; 2004 Sep; 34(5):465-6. PubMed ID: 15220960
    [No Abstract]   [Full Text] [Related]  

  • 37. [Bone marrow transplantation. Recent progress and current indications].
    Jeannet M
    Schweiz Med Wochenschr; 1972 Nov; 102(44):1581-3. PubMed ID: 4405058
    [No Abstract]   [Full Text] [Related]  

  • 38. No beneficial effects, but severe side effects caused by recombinant human tissue plasminogen activator for treatment of hepatic veno-occlusive disease after allogeneic bone marrow transplantation.
    Hägglund H; Ringdén O; Ljungman P; Winiarski J; Ericzon B; Tydén G
    Transplant Proc; 1995 Dec; 27(6):3535. PubMed ID: 8540088
    [No Abstract]   [Full Text] [Related]  

  • 39. Correction of bone marrow failure in dyskeratosis congenita by bone marrow transplantation.
    Ghavamzadeh A; Alimoghadam K; Nasseri P; Jahani M; Khodabandeh A; Ghahremani G
    Bone Marrow Transplant; 1999 Feb; 23(3):299-301. PubMed ID: 10084264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Marrow transplantation for marrow failure or leukemia.
    Thomas ED
    Compr Ther; 1980 Jul; 6(7):69-73. PubMed ID: 7009038
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.